BPG is committed to discovery and dissemination of knowledge
            
            
                
                
                    
    Articles Published Processes
    
        4/27/2018 3:25:40 AM | Browse: 1300 | Download: 1433
    
    
        
        
    
        | 
                
                    |  | Received |  | 2017-12-05 16:15 | 
    
        | 
                
                    |  | Peer-Review Started |  | 2017-12-05 16:46 | 
    
        | 
                
                    |  | To Make the First Decision |  | 2018-01-17 01:26 | 
    
        | 
                
                    |  | Return for Revision |  | 2018-01-18 06:09 | 
    
        | 
                
                    |  | Revised |  | 2018-03-06 15:04 | 
    
        | 
                
                    |  | Second Decision |  | 2018-03-30 10:12 | 
    
        | 
                
                    |  | Accepted by Journal Editor-in-Chief |  |  | 
    
        | 
                
                    |  | Accepted by Executive Editor-in-Chief |  | 2018-03-30 19:03 | 
    
        | 
                
                    |  | Articles in Press |  | 2018-03-30 19:03 | 
    
        | 
                
                    |  | Publication Fee Transferred |  |  | 
    
        | 
                
                    |  | Edit the Manuscript by Language Editor |  |  | 
    
        | 
                
                    |  | Typeset the Manuscript |  | 2018-04-25 11:13 | 
            
                | 
                        
                            |  | Publish the Manuscript Online |  | 2018-04-27 03:25 | 
        
        
            
                | ISSN | 1007-9327 (print) and 2219-2840 (online) | 
            
                | Open Access | This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ | 
            
                | Copyright | © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. | 
                    
                        | Article Reprints | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247 | 
            
            
                | Permissions | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207 | 
            
            
                | Publisher | Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | 
            
                | Website | http://www.wjgnet.com | 
        
    
        | Category | Transplantation | 
    
        | Manuscript Type | Retrospective Cohort Study | 
    
        | Article Title | High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation | 
    
        | Manuscript Source | Unsolicited Manuscript | 
    
        | All Author List | Arnaud Del Bello, Nicolas Congy-Jolivet, Marie Danjoux, Fabrice Muscari, Laurence Lavayssière, Laure Esposito, Anne-Laure Hebral, Julie Bellière and Nassim Kamar | 
            
                | ORCID |  | 
    
        | Funding Agency and Grant Number |  | 
    
        | Corresponding Author | Arnaud Del Bello, MD, Doctor, Doctor, Department of Nephrology and Organ Transplantation, CHU Rangueil, TSA 50032, Cedex 9,, Toulouse 31059, France. delbello.a@chu-toulouse.fr | 
    
        | Key Words | Variability; Liver transplantation; Donor-specific antibodies; Immunosuppression | 
    
        | Core Tip | Tacrolimus intra-patient variability (Tac IPV) was associated with kidney-graft rejection and worse long-term outcomes, but until now, was not well studied after liver transplantation in adult recipients. We found that the coefficient of variability-IPV of tacrolimus was a predictive factor for acute rejection and the occurrence of de novo donor-specific antibodies (DSA) after liver transplantation in a retrospective cohort of 116 recipients treated with tacrolimus and mycophenolate mofetil. This could be a useful tool to identify patients with a greater risk of graft rejection and of developing a de novo DSA after liver transplantation. | 
            
                | Publish Date | 2018-04-27 03:25 | 
    
        | Citation | Del Bello A, Congy-Jolivet N, Danjoux M, Muscari F, Lavayssière L, Esposito L, Hebral AL, Bellière J, Kamar N. High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation. World J Gastroenterol 2018; 24(16): 1795-1802 | 
            
                | URL | http://www.wjgnet.com/1007-9327/full/v24/i16/1795.htm | 
            
                | DOI | http://dx.doi.org/10.3748/wjg.v24.i16.1795 | 
    
    
        
                
        
     
 
                 
             
         
        
    
        
        
            © 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
            California Corporate Number: 3537345